Pharmaniaga Mefenamic

Pharmaniaga Mefenamic

mefenamic acid

Manufacturer:

Pharmaniaga Manufacturing Berhad

Distributor:

Pharmaniaga Logistics
Concise Prescribing Info
Contents
Mefenamic acid
Indications/Uses
Mild to moderate pain, rheumatic disorders, dysmenorrhoea, menorrhagia.
Dosage/Direction for Use
Adult Initially 500 mg, then 250 mg 6 hrly, not exceeding 1 wk.
Administration
Should be taken with food: Take immediately after meals.
Contraindications
Peptic ulceration, inflammatory bowel disease.
Special Precautions
Renal or hepatic impairment. Elderly.
Adverse Reactions
GI disturbances, bleeding peptic ulceration, headache, drowsiness, dizziness, nervousness, visual disturbances, skin rashes, urticaria, haemolytic anaemia agranulocytosis, pancytopenia, thrombocytopenia.
Drug Interactions
Coumarin anticoagulants, lithium, methotrexate, glycosides, phenytoin, sulphonylureas, antihypertensives.
ATC Classification
M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, fenamates.
Presentation/Packing
Form
Pharmaniaga Mefenamic FC tab 500 mg
Packing/Price
50 × 10's
Form
Pharmaniaga Mefenamic cap 250 mg
Packing/Price
50 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in